The European Respiratory Society, 1990-2010: a 20-year anniversary story of success Siafakas N. M. Eur Respir J 2010; 35: 1-2 | |
Does cannabis use predispose to chronic airflow obstruction? Tashkin D. P. Eur Respir J 2010; 35: 3-5 | |
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension Dorfmuller P., Montani D., Humbert M. Eur Respir J 2010; 35: 6-8 | |
Combined pulmonary fibrosis and emphysema: a high-pressure situation Munson J. C. Eur Respir J 2010; 35: 9-11 | |
Is COPD in adulthood really so far removed from early development? Shi W., Warburton D. Eur Respir J 2010; 35: 12-13 | |
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis Johnson S. R., Cordier J. F., Lazor R., Cottin V., Costabel U., Harari S., Reynaud-Gaubert M., Boehler A., Brauner M., Popper H., Bonetti F., Kingswood C., the Review Panel of the ERS LAM Task Force Eur Respir J 2010; 35: 14-26 | |
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD van Zyl Smit R. N., Pai M., Yew W. W., Leung C. C., Zumla A., Bateman E. D., Dheda K. Eur Respir J 2010; 35: 27-33 | |
Measuring airway dimensions during bronchoscopy using anatomical optical coherence tomography Williamson J. P., Armstrong J. J., McLaughlin R. A., Noble P. B., West A. R., Becker S., Curatolo A., Noffsinger W. J., Mitchell H. W., Phillips M. J., Sampson D. D., Hillman D. R., Eastwood P. R. Eur Respir J 2010; 35: 34-41 | |
Effects of cannabis on lung function: a population-based cohort study Hancox R. J., Poulton R., Ely M., Welch D., Taylor D. R., McLachlan C. R., Greene J. M., Moffitt T. E., Caspi A., Sears M. R. Eur Respir J 2010; 35: 42-47 | |
Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study Chakir J., Loubaki L., Laviolette M., Milot J., Biardel S., Jayaram L., Pizzichini M., Pizzichini E., Hargreave F. E., Nair P., Boulet L-P. Eur Respir J 2010; 35: 48-53 | |
Interaction of T-cell and antigen presenting cell co-stimulatory genes in childhood IgE Bottema R. W. B., Postma D. S., Reijmerink N. E., Thijs C., Stelma F. F., Smit H. A., van Schayck C. P., Brunekreef B., Koppelman G. H., Kerkhof M. Eur Respir J 2010; 35: 54-63 | |
Toll-like receptor 7 function is reduced in adolescents with asthma Roponen M., Yerkovich S. T., Hollams E., Sly P. D., Holt P. G., Upham J. W. Eur Respir J 2010; 35: 64-71 | |
Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD Lehtimaki L., Kankaanranta H., Saarelainen S., Annila I., Aine T., Nieminen R., Moilanen E. Eur Respir J 2010; 35: 72-78 | |
Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Hoogendoorn M., van Wetering C. R., Schols A. M., Rutten-van Molken M. P. M. H. Eur Respir J 2010; 35: 79-87 | |
Incidence and outcome of weaning from mechanical ventilation according to new categories Funk G-C., Anders S., Breyer M-K., Burghuber O. C., Edelmann G., Heindl W., Hinterholzer G., Kohansal R., Schuster R., Schwarzmaier-D'Assie A., Valentin A., Hartl S. Eur Respir J 2010; 35: 88-94 | |
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension Mathai S. C., Bueso M., Hummers L. K., Boyce D., Lechtzin N., Le Pavec J., Campo A., Champion H. C., Housten T., Forfia P. R., Zaiman A. L., Wigley F. M., Girgis R. E., Hassoun P. M. Eur Respir J 2010; 35: 95-104 | |
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Cottin V., Le Pavec J., Prevot G., Mal H., Humbert M., Simonneau G., Cordier J-F., GERM"O"P Eur Respir J 2010; 35: 105-111 | |
Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases Gilson M., Zerkak D., Wipff J., Dusser D., Dinh-Xuan A. T., Abitbol V., Chaussade S., Legmann P., Kahan A., Allanore Y. Eur Respir J 2010; 35: 112-117 | |
Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1) Raghu G., King T. E. Jr, Behr J., Brown K. K., du Bois R. M., Leconte I., Roux S., Swigris J. Eur Respir J 2010; 35: 118-123 | |
Control of breathing in children with mild sleep apnoea: a 6-year follow-up study Rice A., Costy-Bennett S., Goodwin J. L., Quan S. F., Fregosi R. F. Eur Respir J 2010; 35: 124-131 | |
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD Machado M-C. L., Vollmer W. M., Togeiro S. M., Bilderback A. L., Oliveira M-V. C., Leitao F. S., Queiroga F. Jr, Lorenzi-Filho G., Krishnan J. A. Eur Respir J 2010; 35: 132-137 | |
A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea Lam J. C. M., Lam B., Yao T. J., Lai A. Y. K., Ooi C. G., Tam S., Lam K. S. L., Ip M. S. M. Eur Respir J 2010; 35: 138-145 | |
Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes Calabro E., Randi G., La Vecchia C., Sverzellati N., Marchiano A., Villani M., Zompatori M., Cassandro R., Harari S., Pastorino U. Eur Respir J 2010; 35: 146-151 | |
Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer Wright C. M., Larsen J. E., Colosimo M. L., Barr J. J., Chen L., McLachlan R. E., Yang I. A., Bowman R. V., Fong K. M. Eur Respir J 2010; 35: 152-159 | |
Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis Montes-Worboys A., Rodriguez-Portal J. A., Arellano-Orden E., Digon-Pereiras J., Rodriguez-Panadero F. Eur Respir J 2010; 35: 160-166 | |
The role of chemokine receptors in acute lung allograft rejection Geleff S., Draganovici D., Jaksch P., Segerer S. Eur Respir J 2010; 35: 167-175 | |
Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles Decologne N., Wettstein G., Kolb M., Margetts P., Garrido C., Camus P., Bonniaud P. Eur Respir J 2010; 35: 176-185 | |
Lung-specific inactivation of CCAAT/enhancer binding protein α causes a pathological pattern characteristic of COPD Didon L., Roos A. B., Elmberger G. P., Gonzalez F. J., Nord M. Eur Respir J 2010; 35: 186-197 | |
What lessons have been learnt from animal models of MRSA in the lung? Martinez-Olondris P., Rigol M., Torres A. Eur Respir J 2010; 35: 198-201 | |
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Demedts I. K., Vermaelen K. Y., van Meerbeeck J. P. Eur Respir J 2010; 35: 202-215 | |
An unusual cause of blindness Seville R. A., Murchison J., Riha R. L. Eur Respir J 2010; 35: 216-217 | |
Culture result of smear-positive sputum samples after 2 months of antituberculous treatment Lim C-S., Lee C-H., Chien Y-J., Wang J-Y., Lee L-N., Yu C-J., Yang P-C., the TAMI group Eur Respir J 2010; 35: 218-220 | |
A complication of peroral bronchoscopy Thompson A. A. R., Raistrick C. S., Pirzada O. M., Anderson P. B. Eur Respir J 2010; 35: 221-222 | |
Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Orfanos S. E., Langleben D. Eur Respir J 2010; 35: 223-224 | |
Nonthrombotic pulmonary embolism Vinatier I., Rivaud E., Tcherakian C., Bisson A., Goudot B., Couderc L. J. Eur Respir J 2010; 35: 224 | |
From the authors: Song Y., Li X., Du X. Eur Respir J 2010; 35: 225-226 | |
To the Editors: Brain J. D., Kreyling W., Gehr P. Eur Respir J 2010; 35: 226-227 | |
From the Editors: The European Respiratory Journal Editors Eur Respir J 2010; 35: 227 | |
Medicines for children in Europe: from proposals to practicalities Bush A., Zach M. Eur Respir J 2010; 35: 228-229 | |